La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
National Research Résultats passés
Passé contrôle des critères 3/6
National Research's earnings have been declining at an average annual rate of -2.8%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 3.9% per year. National Research's return on equity is 72.8%, and it has net margins of 20%.
Informations clés
-2.8%
Taux de croissance des bénéfices
-2.0%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 8.5% |
| Taux de croissance des recettes | 3.9% |
| Rendement des fonds propres | 72.8% |
| Marge nette | 20.0% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12
Jun 19
National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon
Jun 04Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)
May 09National Research's (NASDAQ:NRC) Dividend Will Be $0.12
Feb 20National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Dec 13Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital
Oct 01We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt
Jul 10Why We Like The Returns At National Research (NASDAQ:NRC)
May 04Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
Mar 25National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Nov 17National Research Corp: Market Is Discounting These Key Factors
Sep 18National Research declares $0.24 dividend
Aug 23National Research GAAP EPS of $0.33, revenue of $37.3M
Aug 02National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively
Jul 13Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
May 27National Research Corp.: Quality/Low Risk On Sale
May 17The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested
Mar 21National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly
Feb 11Ventilation des recettes et des dépenses
Comment National Research gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 146 | 29 | 45 | 0 |
| 31 Mar 24 | 147 | 30 | 46 | 0 |
| 31 Dec 23 | 149 | 31 | 47 | 0 |
| 30 Sep 23 | 149 | 29 | 46 | 0 |
| 30 Jun 23 | 148 | 29 | 45 | 0 |
| 31 Mar 23 | 150 | 30 | 44 | 0 |
| 31 Dec 22 | 152 | 32 | 43 | 0 |
| 30 Sep 22 | 152 | 35 | 42 | 0 |
| 30 Jun 22 | 152 | 36 | 41 | 0 |
| 31 Mar 22 | 151 | 37 | 40 | 0 |
| 31 Dec 21 | 148 | 37 | 39 | 0 |
| 30 Sep 21 | 144 | 36 | 38 | 0 |
| 30 Jun 21 | 140 | 36 | 36 | 0 |
| 31 Mar 21 | 135 | 35 | 35 | 0 |
| 31 Dec 20 | 133 | 37 | 34 | 0 |
| 30 Sep 20 | 131 | 38 | 34 | 0 |
| 30 Jun 20 | 130 | 36 | 35 | 0 |
| 31 Mar 20 | 130 | 36 | 34 | 0 |
| 31 Dec 19 | 128 | 32 | 33 | 0 |
| 30 Sep 19 | 126 | 31 | 33 | 0 |
| 30 Jun 19 | 124 | 30 | 32 | 0 |
| 31 Mar 19 | 120 | 31 | 31 | 0 |
| 31 Dec 18 | 120 | 30 | 31 | 0 |
| 30 Sep 18 | 119 | 29 | 31 | 0 |
| 30 Jun 18 | 118 | 26 | 32 | 0 |
| 31 Mar 18 | 118 | 24 | 31 | 0 |
| 31 Dec 17 | 118 | 23 | 30 | 0 |
| 30 Sep 17 | 116 | 22 | 29 | 0 |
| 30 Jun 17 | 114 | 23 | 27 | 0 |
| 31 Mar 17 | 112 | 21 | 28 | 0 |
| 31 Dec 16 | 109 | 20 | 28 | 0 |
| 30 Sep 16 | 107 | 21 | 28 | 0 |
| 30 Jun 16 | 106 | 20 | 28 | 0 |
| 31 Mar 16 | 104 | 19 | 27 | 0 |
| 31 Dec 15 | 102 | 17 | 27 | 0 |
| 30 Sep 15 | 101 | 16 | 28 | 0 |
| 30 Jun 15 | 100 | 16 | 27 | 0 |
| 31 Mar 15 | 99 | 16 | 26 | 0 |
| 31 Dec 14 | 99 | 18 | 25 | 0 |
| 30 Sep 14 | 97 | 18 | 24 | 0 |
| 30 Jun 14 | 95 | 17 | 25 | 0 |
| 31 Mar 14 | 94 | 16 | 25 | 0 |
| 31 Dec 13 | 93 | 15 | 25 | 0 |
| 30 Sep 13 | 92 | 15 | 25 | 0 |
Des revenus de qualité: NRC has high quality earnings.
Augmentation de la marge bénéficiaire: NRC's current net profit margins (20%) are higher than last year (19.6%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: NRC's earnings have declined by 2.8% per year over the past 5 years.
Accélération de la croissance: NRC's earnings growth over the past year (0.4%) exceeds its 5-year average (-2.8% per year).
Bénéfices par rapport au secteur d'activité: NRC earnings growth over the past year (0.4%) did not outperform the Healthcare industry 6%.
Rendement des fonds propres
ROE élevé: Whilst NRC's Return on Equity (72.81%) is outstanding, this metric is skewed due to their high level of debt.